abstract |
According to the present invention, there is provided a modified form of a non-steroidal anti-inflammatory drug (NSAID). The modified NSAIDs according to the present invention provide a novel class of anti-inflammatory agents that provide their therapeutic benefits while at the same time reducing the incidence of side effects commonly observed with such drugs. |